Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00232063 | Long-term Study of Ciclosporin for Atopic Dermatitis | PHASE3 | COMPLETED | - | — | — | May 1, 2004 | - | Nov 2, 2011 | - | — |
| NCT00232076 | Verification Study of Ciclosporin for Atopic Dermatitis | PHASE3 | COMPLETED | - | — | — | May 1, 2004 | - | Nov 2, 2011 | - | — |
| Name | Type | Description |
|---|---|---|
| ciclosporin | DRUG | - |
Inclusion Criteria: * \- Appropriate the definition/diagnosis criteria of atopic dermatitis of the Japanese Dermatological Association * Patients with severest atopic dermatitis \[according to the "Guidelines for Treatment of Atopic Dermatitis 2002, the severity of atopic dermatitis will be classif...